亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

New Class of Compounds for Inhibiting Enzymatic Browning of Food Products

標題
Method of Inhibition of Enzymatic Browning in Food Using of Hypotaurine and Equivalents
詳細技術說明
None
*Abstract

Invention

Appearance and color are important attributes to consumers when selecting and buying fresh foods. However, many fresh food items (e.g. shrimp and fruit) contain enzymes that will produce “browning” of the food over a relatively short period of time. This color change not only adversely affects the visual appeal of the food item, but may also negatively affect flavor and nutritional value. A number of products are currently used to prevent enzymatic browning, but can also cause problems themselves. Sulfites are commonly used by the food industry, but these also can produce a severe allergic reaction in some consumers. Other additives acidify the food, which can lead to other problems. For these reasons, additional compounds that can be used in food preparation are required. Researchers at the University of Florida have discovered a novel compoundin extracts of mussels that effectively inhibits browning of food. Hypotaurine and related compounds appear to be a safe and effective alternative to a number of potentially problematic anti-browning agents currently used in food.

Applications

Added to fresh foods (e.g. fruit, shrimp) and drinks (e.g. apple juice, wine) to prevent enzymatic browning

Advantages

  • Naturally occurring compound found in some food items
  • Could replace allergy-causing sulfites in some foods providing a unique competitive advantage
  • Provides longer lasting protection from enzymatic browning in comparison to citric acid or ascorbic acid, allowing for longer lasting food for market sale and consumption

Technology

The enzymatic browning caused by polyphenol oxidase (PPO) is a major cause of quality loss in fruits and vegetables. Polyphenol oxidase is a copper-containing enzyme that catalyzes the oxidationof o-diphenols to o-quinones, which can further react to form colored pigments. Sulfites and related compounds are powerful inhibitors of enzymatic browning, but their use is limited since they can produce adverse reactions in a significant proportion of the population. Safe and effective alternatives to sulfites could be very useful to the food processing industry. The various chemicals that have been shown to inhibit enzymatic browning can be divided into two major classes: those that act on the enzyme and those that act on the products. In the latter group, acidification with citric acid is commonly used to reduce enzyme activity, or ascorbic acid is used to react with the polyphenols and reduce them to colorless compounds. However, such approaches may only temporarily inhibit enzymatic browning. Thus, use of compounds that inhibit PPO activity is preferable.Potent inhibitors of PPO were discovered in extracts of blue mussels (Mytilus edulis). Characterization of this inhibitory activity resulted in the discovery that hypotaurine is a potent anti-browning agent that may be of value to the food industry.
*IP Issue Date
Oct 22, 2013
*IP Publication Date
Jun 27, 2011
*Principal Investigation

Name: Maurice Marshall

Department:


Name: Kurt Schulbach

Department:

附加資料
Inventor: Ramkumar, Vickram | Mukherjea, Debashree | Rybak, Len
Priority Number: US8648114B2
IPC Current: A01N005502 | A61K003128 | A61K003324
US Class: 514492 | 424649
Assignee Applicant: The Board of Trustees of the Southern Illinois Universityrbondale
Title: Use of transplatin to prevent hearing loss
Usefulness: Use of transplatin to prevent hearing loss
Summary: For treating or preventing cancer, chronic inflammatory pain selected from arthritis and cancer-induced pain, and platinum-based chemotherapy agent-induced toxicity (claimed).
Novelty: Pharmaceutical composition for treating cancer and pain, and preventing side effects of platinum-based chemotherapy agents in a subject comprises transplatin and a second platinum-based chemotherapy agent
主要類別
診斷/治療
細分類別
癌症/腫瘤
申請日期
Feb 2, 2011
申請號碼
8,563,061
其他
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備